Thunder Bridge收购 TBRG 深 沪
已收盘 02-06 16:00:00 美东时间
20.25
-0.570
-2.74%
华盛通- 最 高21.04
- 今 开20.84
- 成交量 12.39万股
- 最 低 20.01
- 昨 收 20.82
- 总市值 3.04亿
- 52周最高 32.00
- 市盈率 静 --
- 换手率 0.83%
- 52周最低 17.86
- 委 比 22.70%
- 总股本 1500.90万
- 历史最高 32.00
- 量 比 0.52
- 振 幅 4.95%
- 历史最低 7.55
- 每 手 1
- 风险率 2.86%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TruBridge Appoints New Chief Business Officer
TruBridge ( ($TBRG) ) has shared an update. On October 1, 2025, TruBridge annou...
2025-10-03 21:48
TruBridge Q2 Adj. EPS $0.54 Beats $0.26 Estimate, Sales $85.73M Miss $87.12M Estimate
TruBridge (NASDAQ:TBRG) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.26 by 109.3 percent. This is a 237.5 percent increase over earnings of $0.16 per share from the same
2025-08-08 15:34
美股大行评级 | 潜在涨幅506%！ JMP首予MBX Biosciences"跑赢大市"评级，目标价38美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117373634651086848.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity：维持Travere Therapeutics(TVTX)"买入"评级，目标价从45美元升至47美元</p> <p>• JMP证券：维持Benitec生物制药(BNTC)"跑赢大市"评级，
2025-04-11 09:36
Stephens & Co. Reiterates Equal-Weight on TruBridge, Maintains $28 Price Target
Stephens & Co. analyst Jeff Garro reiterates TruBridge (NASDAQ:TBRG) with a Equal-Weight and maintains $28 price target.
2025-04-10 20:50
美股大行评级 | 美银证券：维持雅培"买入"评级，目标价从133美元升至150美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1106501041932570625.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Roth MKM：维持CervoMed Inc.(CRVO)"买入"评级，目标价从7美元升至15美元</p> <p>• Oppenheimer：维持Trevi Therapeutics(TRVI)"跑赢大市"评级，目标价从
2025-03-12 11:01
TruBridge Sees Q1 2025 Revenue $85M-$88M Vs $87.59M Est.; FY25 Revenue $345M-$360M Vs $355.976M Est.
Financial GuidanceFor the first quarter of 2025, TruBridge expects to generate:Total revenue between $85 million and $88 millionAdjusted EBITDA between $14 million and $16 millionFor the full year 2025, TruBridge expects
2025-03-11 04:09
TruBridge Expands Board with New Cooperation Agreements
An update from TruBridge ( ($TBRG) ) is now available. On February 11, 2025, Tr...
2025-02-12 21:28
TruBridge Announces COO Departure and Transition Plan
TruBridge ( ($TBRG) ) has issued an update. TruBridge, Inc. announced the depar...
2025-01-02 21:30
TruBridge Appoints Amy O’Keefe to Board of Directors
TruBridge ( ($TBRG) ) has shared an update. TruBridge, Inc., a healthcare solut...
2024-10-22 02:32
Cantor Fitzgerald Reaffirms Their Buy Rating on TruBridge (TBRG)
In a report released yesterday, Sarah James from Cantor Fitzgerald reiterated a...
2024-08-09 20:52
